NivolumabipilimumabCPIspleural mesotheliomaPeMperitoneal mesotheliomaMedlineWeb of ScienceEmbaseChimeric Antigen Receptor T cell therapy+3 more
… treatment in five articles and salvage therapy in 10 articles. Nivolumab and ipilimumab were preferred as treatment in 23 patients over …